focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.10
Bid: 7.10
Ask: 7.48
Change: 0.29 (4.14%)
Spread: 0.38 (5.352%)
Open: 7.02
High: 7.10
Low: 7.00
Prev. Close: 7.00
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Mar 2007 16:12

Synairgen plc20 March 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing Synairgen plcshares to which voting rights are attached: 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights An acquisition or disposal of financial instruments which may result in the acquisition ofshares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): DTR transitional notification of holdings X 3. Full name of person(s) subject to the notification Lansdowne Partners Limited being theobligation: General Partner of Lansdowne Partners Limited Partnership Lansdowne UK Equity Fund Limited Lansdowne Partners International Limited 4. Full name of shareholder(s) (if different from 3.): Morstan Nominees Ltd (Registered Shareholder) 5. Date of the transaction (and date on which the threshold is N/Acrossed or reached if different): 6. Date on which issuer notified: N/A 7. Threshold(s) that is/are crossed or reached: 8% 8. Notified details: A: Voting rights attached to shares Class/type of Situation previous to Resulting situation after the triggering transactionshares the Triggering transaction if possible Number of Number of Number of Number of voting rights % of voting rightsusing the ISIN Shares Voting sharesCODE Rights Direct Direct Indirect Direct Indirect Ordinary Shares 1,950,000 1,950,000 0 0 1,950,000 0.00% 8.99% B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument Period/ Date that may be acquired if rights the instrument is exercised/ converted N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 1,950,000 8.99% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable: Lansdowne Partners International Limited is the parent undertaking of Lansdowne Partners Limited. Proxy Voting: 10. Name of the proxy holder: Lansdowne Partners Limited 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold votingrights: 13. Additional information: Lansdowne Partners Limited being the General Partner of Lansdowne Partners Limited Partnership ("LPLP") controls 1,950,000 voting rights representing 8.99% of the total voting rights. Lansdowne UK Equity Fund Limited owns 1,854,751 voting rights representing 8.55% of the total voting rights. The balancing 0.44% of voting rights is held on behalf of other client funds managed by LPLP. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Jan 20217:00 amRNSInclusion in US ACTIV-2 trial
20th Jan 20217:00 amRNSHome trial recruitment completed
13th Jan 20217:00 amRNSFirst Patient Dosing in Phase III SG018 Trial
6th Jan 20215:10 pmRNSHolding(s) in Company
5th Jan 20215:53 pmRNSHolding(s) in Company
18th Dec 20207:00 amRNSCOVID-19 Clinical Programme Update
10th Dec 202012:57 pmRNSHolding(s) in Company
13th Nov 20205:03 pmRNSHolding(s) in Company
13th Nov 20207:00 amRNSLancet Respiratory Medicine publishes Phase 2 data
10th Nov 20201:47 pmRNSHolding(s) in Company
4th Nov 20205:51 pmRNSHolding(s) in Company
3rd Nov 20209:00 amRNSHolding(s) in Company
2nd Nov 202012:20 pmRNSResult of General Meeting and Total Voting Rights
2nd Nov 20207:00 amRNSResult of Open Offer
28th Oct 202011:20 amRNSHolding(s) in Company
27th Oct 20208:35 amRNSHolding(s) in Company
21st Oct 20209:45 amRNSHolding(s) in Company
21st Oct 20209:40 amRNSHolding(s) in Company
16th Oct 20203:10 pmRNSExercise of Options and Total Voting Rights
15th Oct 20205:35 pmRNSExercise of Options and Total Voting Rights
15th Oct 20201:51 pmRNSDirector/PDMR Shareholding
15th Oct 20207:00 amRNSResults of Placing
14th Oct 20205:32 pmRNSPlacing and Open Offer
12th Oct 202011:05 amRNSSecond Price Monitoring Extn
12th Oct 202011:00 amRNSPrice Monitoring Extension
6th Oct 20208:55 amRNSHolding(s) in Company
2nd Oct 20207:00 amRNSAppointment of Joint Broker
1st Oct 20202:06 pmRNSSecond Price Monitoring Extn
1st Oct 20202:00 pmRNSPrice Monitoring Extension
1st Oct 202011:00 amRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSClinigen signs MAP agreement with Synairgen
29th Sep 20207:00 amRNSSynairgen and Clinigen sign Managed Access Program
29th Sep 20207:00 amRNSInterim results for six months ended 30 June 2020
9th Sep 20207:00 amRNSSynairgen IP Update
8th Sep 20207:00 amRNSPositive interim analysis of SNG001 in COPD
7th Sep 20203:53 pmRNSHolding(s) in Company
3rd Sep 20205:58 pmRNSHolding(s) in Company
1st Sep 20204:41 pmRNSSecond Price Monitoring Extn
1st Sep 20204:36 pmRNSPrice Monitoring Extension
24th Aug 20204:41 pmRNSSecond Price Monitoring Extn
24th Aug 20204:36 pmRNSPrice Monitoring Extension
21st Aug 20205:28 pmRNSHolding(s) in Company
13th Aug 20204:41 pmRNSSecond Price Monitoring Extn
13th Aug 20204:35 pmRNSPrice Monitoring Extension
13th Aug 20207:57 amRNSHolding(s) in Company
10th Aug 20209:50 amRNSHolding(s) in Company
7th Aug 20208:22 amRNSHolding(s) in Company
5th Aug 20205:51 pmRNSHolding(s) in Company
31st Jul 20208:37 amRNSHolding(s) in Company
29th Jul 20204:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.